Interactive map_navigation

Idorsia Pharmaceuticals US Inc.

One Radnor Corporate Center, Suite 101 100 Matsonford Rd Radnor, PA 19087 United States

Cherry Hill, New Jersey, USA

Radnor, Pennsylvania, USA

Allschwil, Switzerland

Shanghai, China

Beijing, China

Munich, Germany

Berlin, Germany

Lörrach, Germany

Paris, France

London, United Kingdom

Madrid, Spain

Idorsia is expanding its global footprint to reach more patients with our transformative treatments. We conduct research, clinical development and commercial operations out of the following locations. Click the pin to find out more.

Paseo Castellana 79 28046, Madrid Spain

Idorsia Pharmaceuticals Spain S.L.

Immeuble Colisée Gardens - Bâtiment B 8-14 Avenue de l'Arche 92 400 Courbevoie France

Idorsia Pharmaceuticals France SAS

Idorsia Pharmaceuticals Germany GmbH

Dachauerstr. 63 DE-80335 München Germany

Headquarters of Idorsia Ltd. Responsible for drug discovery, development, registration, production, quality assurance, safety, as well as company management and coordination.

Hegenheimermattweg 91 4123 Allschwil Switzerland

Idorsia Pharmaceuticals Ltd

www.idorsia.uk

Idorsia Pharmaceuticals UK Ltd

20 Eastbourne Terrace London, W2 6LG United Kingdom

Based in Radnor, Pennsylvania, US – is responsible for the commercial operations in the US.

A 100% subsidiary of Idorsia Ltd, based in London, United Kingdom – is responsible for the Group’s marketing operations in the United Kingdom.

A 100% subsidiary of Idorsia Ltd, based in Munich, Germany – is responsible for the Group’s marketing operations in Germany.

A 100% subsidiary of Idorsia Ltd, based in Paris, France – will be responsible for the Group’s marketing operations in France.

A 100% subsidiary of Idorsia Ltd, based in Madrid, Spain – is responsible for the Group’s marketing in Spain.

Idorsia (Beijing) Pharmaceuticals Co., Ltd

Based in Beijing, PRC – performs clinical development on behalf of Idorsia.

Idorsia (Shanghai) Pharmaceuticals Co., Ltd

Based in Shanghai, PRC – performs research and development on behalf of Idorsia.

Idorsia (Berlin) Pharmaceuticals GmbH

A 100% subsidiary of Idorsia Pharmaceuticals Ltd, based in Berlin, Germany – discovers and develops synthetic carbohydrate vaccines to prevent infection.

Idorsia Pharmaceuticals Deutschland GmbH

A 100% subsidiary of Idorsia Ltd, based in Lörrach, Germany – performs clinical development on behalf of the Group and acts as the Idorsia’s representative for obtaining regulatory approvals in the EU.

Idorsia Clinical Development US Inc.

Based in New Jersey, US – performs clinical development on behalf of Idorsia.

1820 Chapel Avenue West Suite 150 Cherry Hill, NJ 08002 United States

Marie-Curie Str. 8 79539 Lörrach Germany

Room 1102, No 7, Lane 2810 Middle Gaoke Road, New Pudong District Shanghai China

Magnusstrasse 11 12489 Berlin Germany

Room 34, Floor 21, No. 5 Dong San Huan Zhong Road, Chaoyang District, Beijing, 100020 China

Click the arrows to navigate between countries. Click the pin to find out more.

Asia

3/3

Madrid, Spain

Paseo Castellana 79 28046, Madrid Spain

Idorsia Pharmaceuticals Spain S.L.

London, United Kingdom

20 Eastbourne Terrace London, W2 6LG United Kingdom

Idorsia Pharmaceuticals UK Ltd

Paris, France

Immeuble Colisée Gardens - Bâtiment B 8-14 Avenue de l'Arche 92 400 Courbevoie France

Idorsia Pharmaceuticals France SAS

Switzerland, Allschwil

Headquarters of Idorsia Ltd. Hegenheimermattweg 91 4123 Allschwil Switzerland

Idorsia Pharmaceuticals Ltd

Milan, Italy

Via Fabio Filzi 25A 20124 Milano Italy

Idorsia Pharmaceuticals Italy S.R.L.

Munich, Germany

Dachauerstr. 63 DE-80335 München Germany

Idorsia Pharmaceuticals Germany GmbH

Europe

2/3

North America

1/3

Radnor, Pennsylvania, USA

One Radnor Corporate Center, Suite 101 100 Matsonford Rd Radnor, PA 19087 United States

Idorsia Pharmaceuticals US Inc.

Cherry Hill, New Jersey, USA

Based in Radnor, Pennsylvania, US – is responsible for the commercial operations in the US.

1820 Chapel Avenue West Suite 150 Cherry Hill, NJ 08002 United States

Based in New Jersey, US – performs clinical development on behalf of Idorsia.

Idorsia Clinical Development US Inc.

Berlin, Germany

Idorsia (Berlin) Pharmaceuticals GmbH

Magnusstrasse 11 12489 Berlin Germany

A 100% subsidiary of Idorsia Pharmaceuticals Ltd, based in Berlin, Germany – discovers and develops synthetic carbohydrate vaccines to prevent infection.

Lörrach, Germany

Marie-Curie Str. 8 79539 Lörrach Germany

Idorsia Pharmaceuticals Germany GmbH

A 100% subsidiary of Idorsia Ltd, based in Lörrach, Germany – performs clinical development on behalf of the Group and acts as the Group’s representative for obtaining regulatory approvals in the EU.

A 100% subsidiary of Idorsia Ltd, based in Munich, Germany – is responsible for the Group’s marketing operations in Germany.

A 100% subsidiary of Idorsia Ltd, based in Milan, Italy – is responsible for the Group’s marketing operations in Italy.

Headquarters of Idorsia Ltd. Responsible for drug discovery, development, registration, production, quality assurance, safety, as well as company management and coordination.

A 100% subsidiary of Idorsia Ltd, based in Paris, France – will be responsible for the Group’s marketing operations in France.

A 100% subsidiary of Idorsia Ltd, based in London, United Kingdom – is responsible for the Group’s marketing operations in the United Kingdom.

A 100% subsidiary of Idorsia Ltd, based in Madrid, Spain – is responsible for the Group’s marketing in Spain.

Beijing, China

Room 34, Floor 21, No. 5 Dong San Huan Zhong Road, Chaoyang District, Beijing, 100020 China

Idorsia (Beijing) Pharmaceuticals Co., Ltd

Based in Beijing, PRC – performs clinical development on behalf of Idorsia.

Shanghai, China

Room 1102, No 7, Lane 2810 Middle Gaoke Road, New Pudong District Shanghai China

Idorsia (Shanghai) Pharmaceuticals Co., Ltd

Based in Shanghai, PRC – performs research and development on behalf of Idorsia.

www.idorsia.us

www.idorsia.com

www.idorsia.us

www.idorsia.com

www.idorsia.de

www.idorsia.uk

Montreal, Canada

Idorsia Pharmaceuticals Canada Ltd

Based in Montreal, Canada – responsible for the Idorsia’s commercial operations in Canada.

6500 TransCanada Highway suite 220 Pointe Claire, Quebec H9R 0A5 Canada

www.idorsia.com

Stockholm, Sweden

a 100% subsidiary of Idorsia Ltd, based in Stockholm, Sweden – responsible for the Idorsia’s commercial operations in Sweden, Norway, Finland, and Denmark.

Idorsia Pharmaceuticals Nordics AB

Idorsia Pharmaceuticals Italy S.R.L.

Via Fabio Filzi 25A 20124 Milano Italy

A 100% subsidiary of Idorsia Ltd, based in Milan, Italy – is responsible for the Idorsia’s marketing operations in Italy.

www.idorsia.it

Milan, Italy

Montreal, Canada

6500 TransCanada Highway suite 220 Pointe Claire, Québec H9R 0A5 Canada

Based in Québec, Canada – responsible for the Idorsia’s commercial operations in Canada.

Idorsia Pharmaceuticals Canada Ltd

www.idorsia.com

Stockholm, Sweden

c/o FirstOffice, Gustav III:s Boulevard 46, 169 73 Solna, Sweden

A 100% subsidiary of Idorsia Ltd, based in Stockholm, Sweden – responsible for the Idorsia’s commercial operations in Sweden, Norway, Finland, and Denmark.

Idorsia Pharmaceuticals Nordics AB

www.idorsia.es

www.idorsia.it

www.idorsia.es

www.idorsia.uk

www.idorsia.fr

Austria

Idorsia Pharmaceuticals Ltd

Hegenheimermattweg 91 4123 Allschwil Switzerland

A 100% subsidiary of Idorsia Ltd, based in Munich, Germany – is responsible for the Group’s marketing operations in Germany.

www.idorsia.at

Austria

Hegenheimermattweg 91 4123 Allschwil Switzerland

A 100% subsidiary of Idorsia Ltd, based in Munich, Germany – is responsible for the Group’s marketing operations in Germany.

Idorsia Pharmaceuticals Ltd

www.idorsia.at

c/o FirstOffice, Gustav III's Boulevard 46, 169 73 Solna, Sweden